Neuroone Medical Technologies Corp expected to post a loss of 14 cents a share - Earnings Preview

Neuroone Medical Technologies

09/02/2024 22:49

* Neuroone Medical Technologies Corp  NMTC.OQ   NMTC.O  is
expected to show a fall in quarterly revenue when it reports 
results on February 13 for the period ending December 31 2023
    * The Eden Prairie Minnesota-based  company is expected to
report
a 45.7% decrease in revenue to $852 thousand from $1.57 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Neuroone Medical
Technologies
Corp is for a loss of 14 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Neuroone
Medical
Technologies Corp is $2.67​, above​ its last closing price
of $1.45. ​​​

This summary was machine generated February 9 at 22:49 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)